TVTX vs. INDV
TVTX (Travere Therapeutics, Inc.) and INDV (Indivior PLC Ordinary Shares) are both stocks. Both are in the Healthcare sector — TVTX in Biotechnology, INDV in Drug Manufacturers - Specialty & Generic. Over the past 10 years, TVTX returned 11.96%/yr vs 27.71%/yr for INDV. At a 0.08 correlation, their price movements are largely independent.
Performance
TVTX vs. INDV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TVTX achieves a 44.23% return, which is significantly higher than INDV's 6.80% return. Over the past 10 years, TVTX has underperformed INDV with an annualized return of 11.96%, while INDV has yielded a comparatively higher 27.71% annualized return.
TVTX
- 1D
- -0.07%
- 1M
- 24.04%
- YTD
- 44.23%
- 6M
- 50.99%
- 1Y
- 285.12%
- 3Y*
- 50.58%
- 5Y*
- 29.95%
- 10Y*
- 11.96%
INDV
- 1D
- 0.05%
- 1M
- 2.10%
- YTD
- 6.80%
- 6M
- 5.13%
- 1Y
- 173.52%
- 3Y*
- 18.89%
- 5Y*
- 78.24%
- 10Y*
- 27.71%
TVTX vs. INDV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
TVTX Travere Therapeutics, Inc. | 44.23% | 119.35% | 93.77% | -57.25% | -32.25% | 13.89% | 91.94% | -37.25% | 7.40% | 11.30% |
INDV Indivior PLC Ordinary Shares | 6.80% | 188.66% | -18.60% | -29.79% | 530.43% | 135.49% | 181.73% | -61.48% | -75.45% | 54.91% |
Correlation
The correlation between TVTX and INDV is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.28 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.25 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.17 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.08 |
Correlation (All Time) Calculated using the full available price history since Dec 29, 2014 | 0.08 |
The correlation between TVTX and INDV shifts across timeframes, from 0.08 (all time) to 0.28 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
TVTX:
$5.06B
INDV:
$4.94B
TVTX:
-$0.49
INDV:
$1.98
TVTX:
9.60
INDV:
3.78
TVTX:
$536.20M
INDV:
$1.29B
TVTX:
$385.20M
INDV:
$1.05B
TVTX:
$11.15M
INDV:
$362.00M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TVTX vs. INDV — Risk / Return Rank
TVTX
INDV
TVTX vs. INDV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Travere Therapeutics, Inc. (TVTX) and Indivior PLC Ordinary Shares (INDV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TVTX | INDV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.39 | ||
| Sortino ratioReturn per unit of downside risk | -1.23 | ||
| Omega ratioGain probability vs. loss probability | 1.58 | 1.68 | -0.10 |
| Calmar ratioReturn relative to maximum drawdown | 8.58 | 8.17 | +0.40 |
| Martin ratioReturn relative to average drawdown | 19.84 | 23.32 | -3.49 |
Loading charts...
Drawdowns
TVTX vs. INDV - Drawdown Comparison
The maximum TVTX drawdown since its inception was -85.43%, smaller than the maximum INDV drawdown of -93.82%. Use the drawdown chart below to compare losses from any high point for TVTX and INDV.
Loading charts...
Drawdown Indicators
| TVTX | INDV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -85.43% | -93.82% | +8.39% |
Max Drawdown (1Y)Largest decline over 1 year | -33.49% | -21.37% | -12.12% |
Max Drawdown (3Y)Largest decline over 3 years | -69.51% | -69.89% | +0.38% |
Max Drawdown (5Y)Largest decline over 5 years | -83.12% | -69.89% | -13.23% |
Max Drawdown (10Y)Largest decline over 10 years | -83.64% | -93.82% | +10.18% |
Current DrawdownCurrent decline from peak | -0.07% | -5.64% | +5.57% |
Average DrawdownAverage peak-to-trough decline | -41.01% | -38.05% | -2.96% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.45% | 7.47% | +6.98% |
Volatility
TVTX vs. INDV - Volatility Comparison
Travere Therapeutics, Inc. (TVTX) has a higher volatility of 15.32% compared to Indivior PLC Ordinary Shares (INDV) at 9.99%. This indicates that TVTX's price experiences larger fluctuations and is considered to be riskier than INDV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TVTX | INDV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.32% | 9.99% | +5.33% |
Volatility (6M)Calculated over the trailing 6-month period | 52.27% | 25.32% | +26.95% |
Volatility (1Y)Calculated over the trailing 1-year period | 71.76% | 39.76% | +32.00% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 66.48% | 186.85% | -120.37% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 58.40% | 149.39% | -90.99% |
Dividends
TVTX vs. INDV - Dividend Comparison
Neither TVTX nor INDV has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
INDV Indivior PLC Ordinary Shares | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.68% | 1.18% |
TVTX Travere Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
TVTX vs. INDV - Financials Comparison
This section allows you to compare key financial metrics between Travere Therapeutics, Inc. and Indivior PLC Ordinary Shares. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
TVTX vs. INDV - Profitability Comparison
TVTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Travere Therapeutics, Inc. reported a gross profit of 0.00 and revenue of 127.20M. Therefore, the gross margin over that period was 0.0%.
INDV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Indivior PLC Ordinary Shares reported a gross profit of 277.00M and revenue of 317.00M. Therefore, the gross margin over that period was 87.4%.
TVTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Travere Therapeutics, Inc. reported an operating income of -36.60M and revenue of 127.20M, resulting in an operating margin of -28.8%.
INDV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Indivior PLC Ordinary Shares reported an operating income of 137.00M and revenue of 317.00M, resulting in an operating margin of 43.2%.
TVTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Travere Therapeutics, Inc. reported a net income of -37.10M and revenue of 127.20M, resulting in a net margin of -29.2%.
INDV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Indivior PLC Ordinary Shares reported a net income of 89.00M and revenue of 317.00M, resulting in a net margin of 28.1%.
Frequently Asked Questions
TVTX and INDV have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TVTX has higher volatility (15.32%) compared to INDV (9.99%). In terms of maximum drawdown, TVTX dropped -85.43% vs INDV's -93.82%.
INDV currently has the higher Sharpe Ratio (4.40 vs 4.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TVTX and INDV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer